Baluran, Merlyn N.
HRN: 24-42-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2024
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
07/15/2024
07/22/2024
IVT
400mg LD, 100mg
OD
Infected DM Foot, Right
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes